UBE2C and lung carcinoma: The expression of UBE2C can be downregulated through the knockdown of MALAT1, leading to the inactivation of WNT, PI3K/AKT, and MAPK/ERK, thus inhibiting proliferation, migration, and invasion of lung cancer cells [64].